267
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Risk Factors for Legal Blindness in 77 Japanese Patients with Endogenous Endophthalmitis: A Multicenter Cohort Study from J-CREST

, MD, , MD, PhDORCID Icon, , MD, PhD, , MD, PhD, , MD, , MD, PhDORCID Icon, , MD, PhD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, , MD, PhD, , MD, PhD, , MD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, PhD & , MD, PhD show all
Pages 1505-1512 | Received 15 Mar 2022, Accepted 14 Jul 2022, Published online: 25 Aug 2022

References

  • Ben Artsi E, Katz G, Kinori M, Moisseiev J. Endophthalmitis today: a multispecialty ophthalmology department perspective. Eur J Ophthalmol. 2016;26:71–77. doi:10.5301/ejo.5000642.
  • Kitsche M, Herber R, Pillunat LE, Terai N. Clinical and visual outcome of endophthalmitis patients: a single-center experience. Graefes Arch Clin Exp Ophthalmol. 2020;258:183–189. doi:10.1007/s00417-019-04480-2.
  • Malmin A, Syre H, Ushakova A, Utheim TP, Forsaa VA. Twenty years of endophthalmitis: incidence, aetiology and clinical outcome. Acta Ophthalmol. 2021;99:e62–e69. doi:10.1111/aos.14511.
  • Wong JS, Chan TK, Lee HM, Chee SP. Endogenous bacterial endophthalmitis: an east Asian experience and a reappraisal of a severe ocular affliction. Ophthalmology. 2000;107:1483–1491. doi:10.1016/S0161-6420(00)00216-5.
  • Yang XB, Liu YY, Huang ZX, Mao Y, Zhao L, Xu ZP. Clinical analysis of 1593 patients with infectious endophthalmitis: a 12-year study at a tertiary referral center in western China. Chin Med J. 2018;131:1658–1665.
  • Relhan N, Forster RK, Flynn HW Jr. Endophthalmitis: then and now. Am J Ophthalmol. 2018;187:xx–xxvii. doi:10.1016/j.ajo.2017.11.021.
  • Ishikawa H, Uchida K, Takesue Y, et al. Clinical characteristics and outcomes in 314 Japanese patients with bacterial endophthalmitis: a multicenter Cohort study from J-CREST. Pathogens. 2021;10:390. doi:10.3390/pathogens10040390.
  • Bjerrum SS, la Cour M. 59 eyes with endogenous endophthalmitis: causes, outcomes and mortality in a Danish population between 2000 and 2016. Graefes Arch Clin Exp Ophthalmol. 2017;255:2023–2027. doi:10.1007/s00417-017-3760-4.
  • Cunningham ET, Flynn HW, Relhan N, Zierhut M. Endogenous endophthalmitis. Ocul Immunol Inflamm. 2018;26:491–495. doi:10.1080/09273948.2018.1466561.
  • Gounder PA, Hille DM, Khoo YJ, Phagura RS, Chen FK. Endogenous endophthalmitis in Western Australia: a sixteen-year retrospective study. Retina. 2020;40:908–918. doi:10.1097/IAE.0000000000002512.
  • Hsieh MC, Chen SN, Cheng CY, et al. Clinicomicrobiological profile, visual outcome and mortality of culture-proven endogenous endophthalmitis in Taiwan. Sci Rep. 2020;10:12481. doi:10.1038/s41598-020-69251-0.
  • Maling S, King C, Davies N. A British ophthalmological surveillance unit study on metastatic endogenous endophthalmitis. Eye. 2018;32:743–748. doi:10.1038/eye.2017.284.
  • Silpa-Archa S, Ponwong A, Preble JM, Foster CS. Culture-positive endogenous endophthalmitis: an eleven-year retrospective study in the central region of Thailand. Ocul Immunol Inflamm. 2018;26:533–542. doi:10.1080/09273948.2017.1355469.
  • Todokoro D, Mochizuki K, Nishida T, et al. Isolates and antibiotic susceptibilities of endogenous bacterial endophthalmitis: a retrospective multicenter study in Japan. J Infect Chemother. 2018;24:458–462. doi:10.1016/j.jiac.2018.01.019.
  • Uppuluri A, Zarbin MA, Budoff G, Bhagat N. Risk factors for endogenous endophthalmitis in hospitalized patients with Candida fungemia. Ophthalmol Retina. 2020;5:687–695. doi:10.1016/j.oret.2020.10.007.
  • Danielescu C, Anton N, Stanca HT, Munteanu M. Endogenous endophthalmitis: a review of case series published between 2011 and 2020. J Ophthalmol. 2020;2020:8869590. doi:10.1155/2020/8869590.
  • Congdon N, O’Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477–485.
  • Chen YH, Li YH, Lin YJ, et al. Prognostic factors and visual outcomes of pyogenic liver abscess-related endogenous Klebsiella pneumoniae endophthalmitis: a 20-year retrospective review. Sci Rep. 2019;9:1071. doi:10.1038/s41598-018-37643-y.
  • Cho H, Shin YU, Siegel NH, et al. Endogenous endophthalmitis in the American and Korean population: an 8-year retrospective study. Ocul Immunol Inflamm. 2018;26:496–503. doi:10.1080/09273948.2016.1195000.
  • Connell PP, O’Neill EC, Fabinyi D, et al. Endogenous endophthalmitis: 10-year experience at a tertiary referral centre. Eye. 2011;25:66–72. doi:10.1038/eye.2010.145.
  • Lim HW, Shin JW, Cho HY, et al. Endogenous endophthalmitis in the Korean population: a six-year retrospective study. Retina. 2014;34:592–602. doi:10.1097/IAE.0b013e3182a2e705.
  • Chung CY, Wong ES, Liu CCH, Wong MOM, Li KKW. Clinical features and prognostic factors of Klebsiella endophthalmitis-10-year experience in an endemic region. Eye. 2017;31:1569–1575. doi:10.1038/eye.2017.92.
  • Choi EY, Han JY, Lee H, et al. Impact of antibiotic resistance of pathogens and early vitrectomy on the prognosis of infectious endophthalmitis: a 10-year retrospective study. Graefes Arch Clin Exp Ophthalmol. 2019;257:805–813. doi:10.1007/s00417-019-04261-x.
  • Nishida T, Ishida K, Niwa Y, Kawakami H, Mochizuki K, Ohkusu K. An eleven-year retrospective study of endogenous bacterial endophthalmitis. J Ophthalmol. 2015;2015:261310. doi:10.1155/2015/261310.
  • Gomes F, Furtado GE, Henriques M, et al. The skin microbiome of infected pressure ulcers: a review and implications for health professionals. Eur J Clin Invest. 2022;52:e13688. doi:10.1111/eci.13688.
  • Lingappan A, Wykoff CC, Albini TA, et al. Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol. 2012;153:162–166. doi:10.1016/j.ajo.2011.06.020.
  • Lou B, Sun Y, Lin J, et al. Clinical features of endogenous endophthalmitis secondary to minimally invasive upper urinary tract calculus removal. Ocul Immunol Inflamm. 2020;2020:1–7.
  • Chiquet C, Musson C, Aptel F, Boisset S, Maurin M. Genetic and phenotypic traits of Staphylococcus epidermidis strains causing postcataract endophthalmitis compared to commensal conjunctival flora. Am J Ophthalmol. 2018;191:76–82. doi:10.1016/j.ajo.2018.03.042.
  • Kato H, Yoshimura Y, Suido Y, et al. Prevalence of, and risk factors for, hematogenous fungal endophthalmitis in patients with Candida bloodstream infection. Infection. 2018;46:635–640. doi:10.1007/s15010-018-1163-z.
  • Seidelman J, Fleece M, Bloom A, et al. Endogenous Candida endophthalmitis: who is really at risk? J Infect. 2021;82:276–281. doi:10.1016/j.jinf.2020.12.032.
  • Takesue Y, Ueda T, Mikamo H, et al. Management bundles for candidaemia: the impact of compliance on clinical outcomes. J Antimicrob Chemother. 2015;70:587–593. doi:10.1093/jac/dku414.
  • Ueda T, Takesue Y, Tokimatsu I, et al. The incidence of endophthalmitis or macular involvement and the necessity of a routine ophthalmic examination in patients with candidemia. PLoS One. 2019;14:e0216956. doi:10.1371/journal.pone.0216956.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.